Ioannidis, I.; Lefkaritis, G.; Georgiades, S.N.; Pashalidis, I.; Kontoghiorghes, G.J.
Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues. Int. J. Mol. Sci. 2024, 25, 5954.
https://doi.org/10.3390/ijms25115954
AMA Style
Ioannidis I, Lefkaritis G, Georgiades SN, Pashalidis I, Kontoghiorghes GJ.
Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues. International Journal of Molecular Sciences. 2024; 25(11):5954.
https://doi.org/10.3390/ijms25115954
Chicago/Turabian Style
Ioannidis, Ioannis, George Lefkaritis, Savvas N. Georgiades, Ioannis Pashalidis, and George J. Kontoghiorghes.
2024. "Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues" International Journal of Molecular Sciences 25, no. 11: 5954.
https://doi.org/10.3390/ijms25115954
APA Style
Ioannidis, I., Lefkaritis, G., Georgiades, S. N., Pashalidis, I., & Kontoghiorghes, G. J.
(2024). Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues. International Journal of Molecular Sciences, 25(11), 5954.
https://doi.org/10.3390/ijms25115954